US FDA panel votes against accelerated approval of Intercept fatty liver drug

ICPTDelisted Stock  USD 10.31  0.16  1.53%   
Slightly above 61% of Intercept Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Intercept Pharmaceuticals suggests that many traders are alarmed regarding Intercept Pharmaceuticals' prospects. Intercept Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Intercept Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
A panel of advisers to the U.S. Food and Drug Administration on Friday recommended holding off on an accelerated approval of Intercept Pharmaceuticals Incs oral drug for a type of fatty liver disease until more study data is available.

Read at reuters.com
reuters
  

Intercept Pharmaceuticals Fundamental Analysis

We analyze Intercept Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intercept Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intercept Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

Intercept Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Intercept Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intercept Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Intercept Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Intercept Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Intercept Pharmaceuticals Related Equities

HEPAHepion Pharmaceuticals   7.69   
0%
71.0%
VKTXViking Therapeutics   1.12   
10.0%
0%
TERNTerns Pharmaceuticals   2.58   
23.0%
0%
PTCTPTC Therapeutics   3.32   
30.0%
0%
MDGLMadrigal Pharmaceuticals   4.35   
40.0%
0%
SRPTSarepta Therapeutics   4.38   
40.0%
0%
ELEVElevation Oncology   5.97   
55.0%
0%
AKROAkero Therapeutics   6.21   
57.0%
0%
KRYSKrystal Biotech   7.34   
67.0%
0%
TGTXTG Therapeutics   7.45   
68.0%
0%
OCEAOcean Biomedical   7.94   
73.0%
0%
ENVBEnveric Biosciences   10.81   
100.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Intercept Stock

If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA